Thyroid Cancer: Molecular and Translational Aspects on Carcinogenesis and Treatment
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 913
Special Issue Editor
Special Issue Information
Dear Colleagues,
Thyroid cancer (TC) is one of the most prevalent endocrine cancers predominantly found in women. Most recently, thyroid cancer research has led to an improvement in elucidating the molecular mechanisms associated with the initiation and progression of the disease. Nevertheless, there is still an unmet need to test and develop novel therapeutic strategies to extend the survival rate of high-risk TC patients that have not responded to standard therapies.
This Special Issue will focus on the recent advancement in the molecular as well as the translational aspects in thyroid carcinogenesis and treatment options. We would be pleased to receive original research or review articles relevant to this area for this Special Issue from researchers and investigators. Preclinical/emerging/translational research that can identify novel diagnostics and therapeutic strategies would be pleasantly welcomed, and we look forward to your submissions.
Dr. Sonam Kumari
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radioactive iodine (RAI) treatment
- tyrosine kinase inhibitors (TKIs)
- biomarkers
- radiolabeled peptides
- diagnostic markers
- molecular targets
- metastatic progressive thyroid cancer
- overcoming resistance
- personalized therapies
- tumor microenvironment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
